Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients (pts) with advanced NSCLC: Preliminary results of a phase II trial.

被引：0
|
作者：
Hanna, NH
Estes, D
Cress, A
Sidor, C
机构：
[1] Entremed, Rockville, MD USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7105
引用
收藏
页码：642S / 642S
页数：1
相关论文
共 50 条
  • [31] Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: Preliminary results
    Palackdharry, CS
    SEMINARS IN ONCOLOGY, 1996, 23 (03) : 78 - 83
  • [32] Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with relapsed ovarian cancer
    Finkler, Neil J.
    Dizon, Don
    Micha, John
    Braly, Patricia
    Lassen, Ulrik
    Sngelholm, S. A.
    Glasspool, Rosalind
    Crowley, Elizabeth
    Li, Shu-Xia
    Buhl-Jensen, Peter
    Penson, Richard
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3599S - 3599S
  • [33] Volociximab (V) in combination with carboplatin (C) and paclitaxel (P) in patients (pts) with advanced non small cell lung cancer (NSCLC)
    Besse, B.
    Soria, J. C.
    Chico, I.
    Tsao, C.
    Ding, H.
    Belani, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 547 - 547
  • [34] Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
    Jotte, Robert
    Cappuzzo, Federico
    Vynnychenko, Ihor
    Stroyakovskiy, Daniil
    Rodriguez-Abreu, Delvys
    Hussein, Maen
    Soo, Ross
    Conter, Henry J.
    Kozuki, Toshiyuki
    Huang, Kuan-Chieh
    Graupner, Vilma
    Sun, Shawn W.
    Hoang, Tien
    Jessop, Helen
    McCleland, Mark
    Ballinger, Marcus
    Sandler, Alan
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (08) : 1351 - 1360
  • [35] Volociximab (V) in combination with carboplatin (C) and paclitaxel (P) in patients (pts) with advanced non small cell lung cancer (NSCLC)
    Belani, Chandra P.
    Tsao, Claire
    Almokadem, Salah
    Ding, Han
    Chico, Isagani M.
    Soria, Jean-Charles
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S444 - S445
  • [36] Phase I study of combination vemurafenib, carboplatin, and paclitaxel in patients ( pts) with BRAF-mutant advanced cancer
    Kato, Shumei
    Janku, Filip
    Piha-Paul, Sarina Anne
    Naing, Aung
    Karp, Daniel D.
    Tsimberidou, Apostolia Maria
    Subbiah, Vivek
    Zinner, Ralph
    Hwu, Wen-Jen
    Javle, Milind M.
    Parkhurst, Kristin L.
    Ramzanali, Nishma M.
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    Chae, Young Kwang
    Kim, Kevin
    Falchook, Gerald Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma
    Redman, BG
    Smith, DC
    Flaherty, L
    Du, W
    Hussain, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1844 - 1848
  • [38] A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
    Devalingam Mahalingam
    Christos Fountzilas
    Jennifer Moseley
    Nicole Noronha
    Hue Tran
    Romit Chakrabarty
    Giovanni Selvaggi
    Matthew Coffey
    Brad Thompson
    John Sarantopoulos
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 697 - 703
  • [39] A phase II study of REOLYSINA® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
    Mahalingam, Devalingam
    Fountzilas, Christos
    Moseley, Jennifer
    Noronha, Nicole
    Tran, Hue
    Chakrabarty, Romit
    Selvaggi, Giovanni
    Coffey, Matthew
    Thompson, Brad
    Sarantopoulos, John
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 697 - 703
  • [40] Phase II study of combination paclitaxel and carboplatin in patients with advanced or recurrent endometrial cancer.
    Shan, B.
    Wang, H.
    Ren, Y.
    Tu, X.
    Jiang, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345